CRM

Salesforce, Inc.

Technology • CIK: 0001108524

Loading...

Market Cap
$203.31B
P/E (TTM)
27.2x
Rev Growth (TTM)
+9.6%
Net Margin (TTM)
18.0%
FCF Yield (TTM)
7.1%
FCF Margin (TTM)
34.7%

Filing Intelligence

5.0/10
10-K filed Mar 2, 2026FY 2025

Executive Summary

Capital allocation prioritizes returning capital to shareholders through significant share repurchases and dividends, alongside strategic acquisitions like Informatica to bolster AI capabilities.....

Key Concerns

  • The company expresses confidence in its strategic direction and ability to meet financial obligations, while acknowledging risks related to...
  • Significant goodwill and intangible assets ($57.9B total) from multiple large acquisitions (Informatica, Own) in fiscal 2026, with goodwill...
  • Amortization period for capitalized costs to obtain revenue contracts (4 years) is longer than the typical initial contract period, though...

Key Strengths

  • Revenue growth is robust, driven by customer acquisition and expansion in core subscription services, with AI investments positioned as a...
  • Operating margin improved due to revenue growth outpacing expense growth, demonstrating operational leverage. Continued investment in R&D...
  • Strong operating cash flow generation is supported by healthy net income and favorable working capital movements, although an increase in...

LATEST EARNINGS

Q4 FY2026
about 1 month ago
View source
Revenue
$11.20B
+12.1%
Net Income
$1.94B
+13.8%
EPS
$2.07
+18.3%
Gross
77.6% -0.2%
Operating
16.7% -1.5%
Net
17.4% +0.3%
  • Fourth quarter revenue of $11.2 billion, up 12% Y/Y and 10% in CC, including $399 million Informatica contribution.
  • FY26 revenue of $41.5 billion, up 10% Y/Y and 9% in CC, including $399 million Informatica contribution.
  • FY26 operating cash flow of $15.0 billion, up 15% Y/Y, and free cash flow of $14.4 billion, up 16% Y/Y.
  • Announces $50 billion share repurchase program authorization, replacing all previously unused authorizations.

Cash Flow Health

Free Cash Flow8/8 positive
TTM$14.4B
Q4 '26
$5.3B+145%
Q3 '26
$2.2B+260%
FCF Margin
TTM34.7%
Q4 '2647.5%+124%
Sector: 9.1%Top 10%
OCF Margin36.1%
OCF/NI2.01x
CapEx Coverage25.2x
FCF Yield7.1%
FCF Growth (2Y)+32%
Cash Conversion Cycle
63 days
DSO: 63+DIO: 0DPO: 0

Capital Allocation & Returns

Shareholder Friendly
Total Shareholder YieldTTM
TTM7.0%
Div Yield0.8%
+
Buyback (TTM)6.2%

Strong capital returns to shareholders

Dividend & Payout Metrics
Dividend Yield (TTM)0.8%
FCF Payout Ratio11.0%
Free Cash Flow (TTM)$14.4B
Stock Repurchases (TTM)$12.6B
Capital Return / FCF98.5%
Est. Dividends Paid (TTM)$1.6B
Shows how management rewards shareholders

Operational Efficiency & Returns

Return on Invested CapitalTTM
9.4%
Stable
+0.0% YoY+0.9%
P25MedianP75
75th pctl (med: 0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
15.8%
8Q: 15.6%
Asset Turnover
0.42x
8Q: 0.41x
Leverage (1+D/E)
1.24x
D/E: 0.24x
DuPont: 8.2%9.4% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
13.17x
8Q:12.18x
+404.3%
Invested Cap Turn
0.67x
8Q:0.64x
+11.4%
CapEx Intensity
1.0%
8Q:1.0%
CapEx/Depreciation
0.16x
Asset-based ROIC formula

QUARTERLY TRENDS

Last 8 quarters + TTM

MetricTTMQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
$41.5B
$11.2B9.2%
$10.3B0.2%
$10.2B4.1%
$9.8B1.6%
$10.0B5.8%
$9.4B1.3%
$9.3B2.1%
$9.1B
Operating Income
$8.3B
$1.9B14.6%
$2.2B6.2%
$2.3B20.1%
$1.9B6.7%
$1.8B3.9%
$1.9B6.2%
$1.8B4.3%
$1.7B
Net Income
$7.5B
$1.9B6.9%
$2.1B10.5%
$1.9B22.5%
$1.5B9.8%
$1.7B11.9%
$1.5B6.9%
$1.4B6.8%
$1.5B
Operating Cash Flow
$15.0B
$5.5B135.9%
$2.3B213.0%
$740.0M88.6%
$6.5B63.1%
$4.0B100.2%
$2.0B122.3%
$892.0M85.7%
$6.2B
Free Cash Flow
$14.4B
$5.3B144.5%
$2.2B259.8%
$605.0M90.4%
$6.3B65.0%
$3.8B114.5%
$1.8B135.6%
$755.0M87.6%
$6.1B
Total Equity
N/A

Valuation Analysis

Fair Value
Price-to-EarningsTTM
27.2x
Volatile
8Q: 168.6x-7763%
Valuation Lenses
Earnings
27.2x
vs sector
Cash Flow
13.8x
EV/FCF vs
Growth-Adj
1.2xPEG
Fair for growth
Quality-Adj
2.9P/E per %ROIC
ROIC: 9.4%
Shareholder Returns
Dividend
0.8%
Buyback
6.2%
Total Yield
7.0%
Market Cap$203.31B
EV$198.52B
Multi-angle valuation analysis with sector context

Business Quality & Moat

Overall Quality Score
80/100
Exceptional

Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)

Returns on Capital

Return on Equity (ROE)Above Avg
12.3%
8Q:
Return on Invested Capital (ROIC)Top 25%
9.4%
8Q:
Flat
vs Sector:0.1%

DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)

NOPAT Margin: 15.8%
Asset Turnover: 0.42x

Earnings Quality

Cash Conversion

2.01x

OCF / Net Income

FCF Consistency

Positive quarters

Competitive Moat Indicators

Pricing Power

Gross Margin77.7%

Capital Efficiency

Invested Capital Turnover0.67x

Working Capital

Cash Conversion Cycle63 days

Growth Quality & Momentum

Moderate Growth
Growth Quality Score
70/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%

Growth Rates

Revenue Growth YoY
9.6%
OpInc Growth YoY
2.7%
EPS Growth YoY
22.6%
FCF 3Y CAGR
31.6%

Growth Quality Analysis

Efficient Growth: Free cash flow growing faster than revenue

Margin Quality & Sustainability

Low Quality
Profitability Cascade
Gross
77.7%
Operating
20.1%
Top 25% in sector
Net
18.0%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
FCF vs Net Gap
+16.7 pts
FCF: 34.7% | Net: 18.0%

Quality = stability + cash conversion + low dilution

Balance Sheet & Solvency

Solid
Net Debt / EBITDA
Net Debt: $4.87B
Interest Coverage
Balance sheet risk & solvency analysis